|
Financial Times Deutschland Since its launch on February 21st 2000 Financial
Times Deutschland stands for modern, intelligent business and financial
journalism. Its journalistic motto is: choice and opinion. FTD reports
critically and comprehensively, quickly getting to the very heart
of complex issues. It covers topics from the Old Economy as well
as E-Business and growth industries. "One brand, all forms
of media" - FTD thinks and acts in a networked manner. Thus
the news in the print edition is augmented by its internet service,
SMS and WAP services, Palm downloads or information for the Rocket
eBook as well as the FTD audio service. This means up-to-date coverage,
even after the copy deadline. It means business news anytime, anywhere.
|
 |
|
BIOISRAEL.com is the hub site of Israel's life science community. BioIsrael's Internet portal and newsletter link Israeli companies with the international biopharmaceutical and financial communities. Aiming to accelerate strategic alliances and promote investments, BioIsrael:
|
 |
|
Bio.com, "the original web site dedicated
to the life sciences", is the premiere Internet destination
for the life science community and biotechnology industry. As one
of the first 50 websites in existence, Bio.com, at www.bio.com,
has a great history and presence in the life sciences community.
Researchers and relateed professionals visit the site regularly
as a convenient one-stop resource for the latest news, articles,
careers, career advice, live scientific discussions, protocols,
software, publications, journals, company profiles, industry reports,
and events calendar. For more information, visit www.bio.com. |
 |
|
BioSpace, Inc. is a specialized provider
of web-based products and information services to the life sciences.
The company’s premier Website, www.biospace.com
is the Internet’s most comprehensive life sciences-related
information and service resource, attracting 800,000 unique visitors
and over 4 million page views monthly. Recognizing the tidal wave
of information being published in the life sciences, BioSpace has
developed products and services that more efficiently deliver information
in a context that is relevant to the end user. Offered both on the
Internet, or an enterprise Intranet, BioSpace’s suite of Enterprise
Portal Services includes an information management tool called BioSpace
LInKS™ Solution, and CCIS, a Clinical Competitive Intelligence
System. Additionally the company leverages its extensive online
community to offer highly popular life sciences industry Career
Fairs. San Francisco-based BioSpace.com was launched in 1995. |
 |
|
BioVenture View is the definitive twice-monthly newsletter for the global biotechnology industry and has been providing senior executives with the information they need to stay ahead of the competition. Each monthly issue provides an informative and incisive package of analysis and data, including:
|
 |
|
Business Wire delivers more news from more sources to more destinations than any other service in the world. With content from more than 34,000 organisations, Business Wire delivers breaking news and multimedia content to domestic and international media, and distributes news to more than 16,000 online database sites worldwide. Business Wire’s domestic and international offices are strategically positioned to navigate your tradeshow announcements, investor relations, public relations and corporate communications programmes to your specialized media audiences and shareholders. It is imperative that professional communicators have the means to reach the media and investment community with their corporate news – domestically and internationally. As a recognized source for material news dissemination by major global exchanges, trading systems and regulatory bodies, Business Wire provides simultaneous delivery of your breaking news to disclosure media throughout the world. For additional information on Business Wire’s media, tradeshow, investor relations, and public relations products and services, please contact Uksales@bizwire.com. |
 |
|
Finance is a new monthly from two of the
leading German publishing houses, Frankfurter Allgemeine Zeitung
and manager magazin. FINANCE is the first authoritative publication
on all aspects of the corporate finance market in Germany. Editorial
topics are mergers and acquisitions, venture capital, going public,
buy-outs and private equity. FINANCE particularly emphasizes the
German medium-sized and start-up company sector. The guaranteed
circulation is 25,000 copies a month. The price for annual subscription
is DEM 126,-. For subscription please call +49 40 3007 25 34, or
fax +49 40 3007 3070. Since May 01 FINANCE has also gone into retail
sale and the price is DEM 12. |
 |
|
Going Public Media AG is part of the young and thriving German VC and IPO scene as one of the leading information providers. The Company focuses mainly on research and coverage of current and near-term IPO-candidates on the Neuer Markt, Germany's stock market for high-tech, high-growth companies. Following a cross-media strategy, the Company
is committed to exploring new trends, topics and technologies such
as New Media, Biotechnology and Venture Capital. Consequently, the
first subsidiary company, Biotech Media GmbH, was established on
February 1st 2000 in continental Europe's premier financial center,
Frankfurt. |
 |
|
Nature Biotechnology For over 130 years, the Nature Publishing Group
has delivered high-quality, fairly priced information to the global
science market. Nature continually provides over 660,000 readers
with the most up-to-date scientific developments and independent
editorial comment from around the world. And our research journals
offer exciting and high-impact research and the latest scientific
News & Views within their respective disciplines. Keeping up with the deluge of scientific research
is a constant challenge for those in science and business whose
time is valuable and limited. Nature Biotechnology aims to cut through
the noise and present only the hard data, essential news, and expert
analysis of biotechnology research in scientific and commercial
development. Providing a one-stop digest of the research that is
transforming biology and generating the future products for healthcare,
agriculture, and the environment. Over 17 years of experience ensures
that Nature Biotechnology will provide you with the essential research
for the business of biotechnology. |
 |